DK0527494T3 - Præparat indeholdende rhodacyanin-farvestoffer til behandling af cancer - Google Patents

Præparat indeholdende rhodacyanin-farvestoffer til behandling af cancer

Info

Publication number
DK0527494T3
DK0527494T3 DK92113812.9T DK92113812T DK0527494T3 DK 0527494 T3 DK0527494 T3 DK 0527494T3 DK 92113812 T DK92113812 T DK 92113812T DK 0527494 T3 DK0527494 T3 DK 0527494T3
Authority
DK
Denmark
Prior art keywords
different
same
group
chem
alkyl group
Prior art date
Application number
DK92113812.9T
Other languages
Danish (da)
English (en)
Inventor
Lan Bo Cen
Tadao Shishido
Original Assignee
Fuji Photo Film Co Ltd
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Photo Film Co Ltd, Dana Farber Cancer Inst Inc filed Critical Fuji Photo Film Co Ltd
Application granted granted Critical
Publication of DK0527494T3 publication Critical patent/DK0527494T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Gas Separation By Absorption (AREA)
  • Paper (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK92113812.9T 1991-08-13 1992-08-13 Præparat indeholdende rhodacyanin-farvestoffer til behandling af cancer DK0527494T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74413091A 1991-08-13 1991-08-13

Publications (1)

Publication Number Publication Date
DK0527494T3 true DK0527494T3 (da) 1996-11-25

Family

ID=24991548

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92113812.9T DK0527494T3 (da) 1991-08-13 1992-08-13 Præparat indeholdende rhodacyanin-farvestoffer til behandling af cancer

Country Status (15)

Country Link
US (1) US5360803A (fi)
EP (1) EP0527494B1 (fi)
JP (1) JP2567328B2 (fi)
CN (1) CN1071834A (fi)
AT (1) ATE144897T1 (fi)
AU (1) AU649865B2 (fi)
CA (1) CA2075750C (fi)
DE (1) DE69215035T2 (fi)
DK (1) DK0527494T3 (fi)
ES (1) ES2096685T3 (fi)
FI (1) FI923604A (fi)
GR (1) GR3021865T3 (fi)
HU (1) HUT64224A (fi)
NO (1) NO923126L (fi)
ZA (1) ZA926004B (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU678116B2 (en) * 1994-07-21 1997-05-15 Fuji Photo Film Co., Ltd. Water-soluble methine compound and pharmaceutical composition for treatment of cancer comprising the same
US5599825A (en) * 1994-07-21 1997-02-04 Fuji Photo Film Co., Ltd. Water-soluble methine compound and pharmaceutical composition for treatment of cancer comprising the same
JPH0921985A (ja) * 1995-07-07 1997-01-21 Nec Corp マッハツェンダー変調器及びその製造方法
EP0761216B1 (en) 1995-08-16 2003-11-12 Huntington Medical Research Institutes Rhodamine 123 compositions for treating prostate cancer
US7329741B2 (en) * 1996-06-05 2008-02-12 Chiron Corporation Polynucleotides that hybridize to DP-75 and their use
DE19908535A1 (de) 1999-02-26 2000-08-31 Aventis Pharma Gmbh Verwendung von polycyclischen Thiazol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
DE10032290C2 (de) * 2000-07-03 2002-05-08 Roche Diagnostics Gmbh Adsorptionsmittelhaltige Kontrollflüssigkeit
JP2003034641A (ja) * 2001-07-19 2003-02-07 Japan Science & Technology Corp ロダシアニン系色素化合物を含有する抗マラリア剤
TW200408407A (en) * 2001-11-30 2004-06-01 Dana Farber Cancer Inst Inc Methods and compositions for modulating the immune system and uses thereof
JP2004331545A (ja) * 2003-05-06 2004-11-25 Japan Science & Technology Agency 抗リーシュマニア剤
FR2874319B1 (fr) * 2004-08-19 2008-05-16 Oreal Composition pour la teinture des fibres keratiniques comprenant un colorant direct methinique contenant un motif benzoselenazolium
JP4553355B2 (ja) 2004-10-04 2010-09-29 富士フイルム株式会社 トリパノソーマ原虫寄生感染症の予防又は治療用医薬組成物
US20060099712A1 (en) * 2004-11-08 2006-05-11 Eastman Kodak Company Correlation of anti-cancer activity of dyes with redox potentials
US8293716B2 (en) 2005-05-26 2012-10-23 Ramot At Tel Aviv University Ltd. Method of treating cancer by modulation of mortalin
GB0603455D0 (en) * 2006-02-21 2006-04-05 Cancer Rec Tech Ltd Therapeutic compounds
WO2008032324A2 (en) * 2006-09-14 2008-03-20 Ramot At Tel Aviv University Ltd. Combination therapy for tumoral disease treatment
WO2009040819A2 (en) 2007-09-25 2009-04-02 Ramot At Tel Aviv University Ltd. DOWN-REGULATION OF MORTALIN BY siRNA
US9642843B2 (en) 2013-02-27 2017-05-09 The Regents Of The University Of Michigan Pharmaceutical compounds and use of same in cancer and tauopathies
CN104177312B (zh) * 2013-05-27 2018-02-13 黄英武 一种含硒化合物及其医药用途
US10221171B2 (en) 2015-01-09 2019-03-05 The Regents Of The University Of California Oxathiazole thiazolium Hsp 70 inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2536986A (en) * 1951-01-02 Thiazolone cyan
GB487051A (en) * 1936-11-14 1938-06-14 John David Kendall Improvements in or relating to dyestuffs
GB489335A (en) * 1937-01-22 1938-07-22 Douglas James Fry Improvements in or relating to the manufacture and use of dyestuffs suitable for sensitising photographic emulsions
US2454629A (en) * 1940-01-27 1948-11-23 Eastman Kodak Co Polymethine dyes
BE485784A (fi) * 1947-11-18
BE571507A (fi) * 1957-09-30
DE1493524A1 (de) * 1962-08-17 1969-06-04 Ciba Geigy Aminosaeuren
JPS53144727A (en) * 1977-05-24 1978-12-16 Konishiroku Photo Ind Co Ltd Photographic product
JPS55100318A (en) * 1979-01-26 1980-07-31 Takeda Chem Ind Ltd Antitumorigenic agent
DE2919447A1 (de) * 1978-05-17 1979-11-22 Takeda Chemical Industries Ltd Tumorhemmendes mittel
JPS5569513A (en) * 1978-11-20 1980-05-26 Takeda Chem Ind Ltd Anti-tumor agent
JPS54151133A (en) * 1978-05-17 1979-11-28 Takeda Chem Ind Ltd Antitumorigenic agent
AU1144688A (en) * 1987-03-17 1988-09-15 Dana-Farber Cancer Institute, Inc. A pharmaceutical composition comprising cyanine dye
JPH0652210B2 (ja) * 1987-08-26 1994-07-06 宣行 杉村 アキユムレ−タのガス封入圧力測定方法
JP2824917B2 (ja) * 1989-08-30 1998-11-18 株式会社林原生物化学研究所 抗腫瘍剤

Also Published As

Publication number Publication date
CA2075750C (en) 1998-02-24
ATE144897T1 (de) 1996-11-15
CN1071834A (zh) 1993-05-12
HUT64224A (en) 1993-12-28
AU649865B2 (en) 1994-06-02
EP0527494A1 (en) 1993-02-17
GR3021865T3 (en) 1997-03-31
ZA926004B (en) 1993-03-02
FI923604A (fi) 1993-02-14
CA2075750A1 (en) 1993-02-14
NO923126L (no) 1993-02-15
AU2097492A (en) 1993-02-25
NO923126D0 (no) 1992-08-11
DE69215035D1 (de) 1996-12-12
ES2096685T3 (es) 1997-03-16
HU9202609D0 (en) 1992-10-28
JPH06172330A (ja) 1994-06-21
DE69215035T2 (de) 1997-04-03
US5360803A (en) 1994-11-01
FI923604A0 (fi) 1992-08-12
JP2567328B2 (ja) 1996-12-25
EP0527494B1 (en) 1996-11-06

Similar Documents

Publication Publication Date Title
DK0527494T3 (da) Præparat indeholdende rhodacyanin-farvestoffer til behandling af cancer
ATE184000T1 (de) 2-oxindolderivate als tyrosinekinaseinhibitoren
ATE211734T1 (de) Stickstoff enthaltende hydrocyclische verbindungen
SE8008680L (sv) Basiska etrar, sett for deras framstellning och farmaceutiska beredningar innehallande dem
ES8600288A1 (es) Un procedimiento para la preparacion de derivados de quinolina.
DE69011569D1 (de) Verbindungen der 1-Azabicyclo(3.2.0)hept-2-en-2-carbonsäure.
NO306992B1 (no) Quinolinderivater, farmasoeytiske preparater inneholdende forbindelsene og anvendelsen av forbindelsene
ATE32894T1 (de) Thiomethylpyridin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ES8702433A1 (es) Un procedimiento para la preparacion de un compuesto heterociclico sustituido con peptidos.
ATE18221T1 (de) (1-arylcyclobutyl)(heterocyclyl)methylaminderivate, ihre herstellung und ihre verwendung als arzneimittel.
PT87025A (pt) Process for the preparation of imidazol derivatives and of pharmaceutical compositions containing the same
ATE120562T1 (de) Verfahren zum härten von gelatine.
ES2024332A6 (es) Procedimiento para la obtencion de nuevas sulfonamidas.
ATE148462T1 (de) Isoxazole derivate als lichtschutzmittel
ES8305751A1 (es) Procedimiento para la obtencion de derivados del ditiol-1,2 ilideno-3 amonio.
DE69528984T2 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
DK601883D0 (da) Phenyl-propanolderivater
TH8849EX (th) 8-ซับสทิทิวเทด-2-อะมิโนเททระลีนชนิดใหม่
TH17758A (th) สารเคมี
MY104164A (en) Heterocyclic compounds.